A diabetic foot ulcer (DFU) is an open wound on the foot in a patient with diabetes — and it is a medical emergency with a clear mortality signal. Approximately 25% of diabetic patients will develop a foot ulcer during their lifetime; 15–25% of those will require amputation; and 5-year mortality after a diabetic foot amputation exceeds that of most common cancers. Understanding the cascade from neuropathy → pressure → ulceration → infection → amputation is essential for prevention and early intervention.

The Diabetic Foot Ulcer Triad

Virtually all diabetic foot ulcers result from the combination of three factors: neuropathy (inability to feel pain from pressure), peripheral arterial disease (impaired healing), and repetitive trauma (a pressure point that would hurt in a sensate person, but doesn’t hurt in a neuropathic foot). Remove any one of these three factors and the ulcer either doesn’t form or heals. This is why the treatment and prevention of DFU is biomechanical (offloading) as much as it is medical.

Wagner Classification of Diabetic Foot Ulcers

• Grade 0: Intact skin; pre-ulcerative lesion (callus over pressure point, blistering, skin breakdown) — treat aggressively to prevent ulceration
• Grade 1: Superficial ulcer; extends through skin only; no subcutaneous involvement; treat with debridement + offloading
• Grade 2: Deep ulcer to tendon, capsule, or bone without bone infection; requires aggressive wound care and often hospital-level evaluation
• Grade 3: Deep ulcer with osteomyelitis or abscess formation; requires hospitalization, IV antibiotics, and surgical debridement/bone resection
• Grade 4: Gangrene of a portion of the foot (forefoot or toe); requires vascular evaluation and likely amputation of affected portion
• Grade 5: Gangrene of the entire foot; major amputation required

Wound Care for Grade 1–2 Diabetic Foot Ulcers

Grade 1–2 ulcers that are not infected and have adequate blood supply can be managed in an outpatient podiatric wound care setting.

• Sharp debridement: Removal of necrotic and hyperkeratotic tissue surrounding the ulcer; the single most evidence-based intervention for DFU healing; stimulates wound bed granulation and removes bacterial biofilm. Must be performed by a trained podiatrist — not a bandage change.
• Total contact casting (TCC): The gold standard offloading device; custom plaster or fiberglass cast that distributes weight across the entire plantar surface; removes all peak pressure from the ulcer site; superior to any removable device for Grade 1–2 plantar forefoot ulcers. Heals 86–90% of Grade 1 ulcers within 5–7 weeks in appropriately selected patients.
• Instant total contact cast (iTCC): Removable CAM boot wrapped in cohesive bandage to make it non-removable; practical alternative to plaster TCC; outcomes comparable when compliance is controlled.
• Non-adherent dressings: Mepilex Ag (silver) for infected or at-risk wounds; Adaptic/Xeroform non-adherent for clean wounds; Aquacel Ag for highly exudating wounds. The dressing type matters less than debridement and offloading.
• Advanced wound care products: Becaplermin gel (PDGF), collagen matrix products, skin substitutes (Apligraf, Dermagraft) for stalled wounds (no 50% size reduction at 4 weeks); significantly increase healing rates in recalcitrant wounds.

Infection: When to Hospitalize

Infected diabetic foot ulcers require urgent evaluation and often inpatient care. The IDSA classification guides management:

• Mild infection: ≤2cm cellulitis around wound; no systemic signs; oral antibiotics as outpatient appropriate (amoxicillin-clavulanate or trimethoprim-sulfamethoxazole based on culture)
• Moderate infection: >2cm cellulitis OR deeper tissue involvement (fascia, muscle, joint) with no systemic signs; IV antibiotics; imaging to rule out osteomyelitis; consider admission
• Severe infection: Any systemic signs (fever, leukocytosis, hypotension, tachycardia); emergent hospital admission; broad-spectrum IV antibiotics (vancomycin + pip/tazo); surgical consultation for source control
• Red flags requiring ER referral: Fever, rapidly spreading redness (tracks toward leg), streaking lymphangitis, altered mental status, inability to weight-bear, gas in tissue on X-ray (necrotizing fasciitis)

Osteomyelitis Diagnosis

Bone infection complicates 15–20% of DFU presentations and is critical to identify because it changes management from wound care to bone surgery. The probe-to-bone test (inserting a sterile blunt metal probe into the ulcer base; touching bone = positive) has 89% sensitivity for osteomyelitis in infected wounds. MRI is the gold standard imaging; X-ray changes appear 10–21 days after infection begins. ESR >70 mm/hr in a diabetic with a foot ulcer has a high positive predictive value for osteomyelitis.

Prevention: The Entire Point

Every prevention strategy is more important than any treatment strategy, because prevention works. The evidence-based prevention protocol for all diabetic patients:

• Annual comprehensive podiatric foot exam: Monofilament (5.07/10g), tuning fork, ABI, visual inspection, nail assessment
• Daily self-inspection: Mirror for plantar surface; inspect every digit; any redness or new wound = podiatric evaluation within 24 hours
• Therapeutic footwear program: Medicare-covered A5500 diabetic shoes + A5512 custom molded insoles for qualifying patients; eliminates the most common pressure ulcer triggers
• Professional callus management: Never self-treat calluses with blades, file grinders, or over-the-counter acids; callus removal by a podiatrist reduces plantar pressure by 25–30%
• Never go barefoot: On any surface; neuropathic feet cannot feel the glass, nail, or pebble that creates the wound entry point
• HbA1c optimization: Poor glucose control slows wound healing; HbA1c <7.5% is the target for patients with active foot wounds

Diabetic Foot Care at Balance Foot & Ankle

Dr. Biernacki provides comprehensive diabetic foot care including annual exams, wound debridement, total contact casting, therapeutic shoe prescription, and coordination with vascular surgery when ABI findings indicate arterial compromise. Schedule a same-day evaluation or call (810) 206-1402. Any new wound in a diabetic patient should be evaluated within 24 hours — not deferred.